Intech Biopharm

Intech Biopharm Inventory

The Inventory of Intech Biopharm (6461.TWO) as of Oct 19, 2026 is 116.48 M TWD. In the previous year, Inventory was 63.86 M TWD — a change of 82.41% (higher).

Inventory

116.48 MTWD

YoY

82.41%

Last updated:

Inventory of Intech Biopharm is 2025 116.48 M TWD. Inventory of Intech Biopharm was 2024 63.86 M TWD. It decreases by 82.41% higher compared to the previous year.

The Intech Biopharm Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
16.37 M TWD
Jan 1, 2019
44.42 M TWD
Jan 1, 2020
56.97 M TWD
Jan 1, 2021
59.87 M TWD
Jan 1, 2022
51.82 M TWD
Jan 1, 2023
41.53 M TWD
Jan 1, 2024
63.86 M TWD
Jan 1, 2025
116.48 M TWD
The Intech Biopharm Inventory history
YEARInventoryYoY
116.48 MTWD+82.41%
63.86 MTWD+53.78%
41.53 MTWD-19.86%
51.82 MTWD-13.46%
59.87 MTWD+5.09%
56.97 MTWD+28.27%
44.42 MTWD+171.29%
16.37 MTWD+675.92%
2.11 MTWD+116.19%
976,000.00TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Intech Biopharm Stock analysis

What does Intech Biopharm do? Intech Biopharm Ltd is a pharmaceutical company based in Taipei City, Taiwan. The company went public on July 15, 2014, with the ticker symbol 6461.TWO and ISIN TW0006461007. It operates within the Health Care sector, specifically in the Pharmaceuticals industry. Intech Biopharm focuses on developing drugs for obstructive airway diseases, including bronchial asthma and chronic obstructive pulmonary disease. The company's primary products are respiratory drugs, notably the Duasma hexafluoroacetone (HFA) metered-dose inhalers (MDIs) and the Synvent HFA MDIs. These products are distributed both domestically within Taiwan and internationally. The company maintains a website at http://www.intechbiopharm.com/ for further information. Intech Biopharm Ltd is engaged in the research, development, and distribution of pharmaceutical products targeting respiratory conditions, with a focus on innovative inhaler technologies. The firm's operations are centered on addressing unmet medical needs in respiratory care through its specialized drug formulations. Intech Biopharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intech Biopharm stock

Inventory of Intech Biopharm is 116.48 M TWD in 2025.

Inventory of Intech Biopharm changed from 63.86 M TWD to 116.48 M TWD, representing a 82.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Intech Biopharm since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Intech Biopharm historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Intech Biopharm

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Intech Biopharm